Background. Regulatory T (Treg) cell plays a key role in autoimmune diseases. We evaluated the regulatory function and frequency of Treg cells and secreted IL-10, IL-35 concentration in Crohn's disease (CD).
INTRODUCTION
Crohn's disease (CD) is an inflammatory bowel disease (IBD) characterized by chronic relapsing immune-mediated inflammation that can affect various sections of the gastrointestinal tract (GIT) [1, 2] . Although the aetiology of CD remains poorly understood, several genetic and immune factors have been implicated in the pathogenesis of inflammatory disorders such as CD. Many studies indicate that the disease is caused by an improper mucosal immune response to microbial flora of GI, which eventually leads to chronic intestinal inflammation. These studies also stated that failure of immunological tolerance toward intestinal antigens plays a key role in the pathogenesis of CD.
Regulatory T cells (Tregs) constitute a permanent lineage of dedicated regulator cells and they arecritical for suppression of immune responses and maintenance of homeostasis by promoting peripheral tolerance to self-antigens [3] . Their role in the development of pathology has previously been explored. Thus, impaired tolerance and occurrence of autoimmune diseases may be due to the defective regulatory function of Tregs [4, 5] . Tregs are characterized by expression of CD4 + , CD25 + and low expression of CD127 (IL-7 receptor α). Moreover, FOXP3 is expressed as a specific molecular marker for discrimination between activated regulatory T-cells and other cells like activated CD4 + T-cells [6] . There is association between lack of FOXP3 protein expression and scurfy phenotype in mice and also with immune dysregulation, polyendocrinopathy, enteropathy X-linked syndrome (IPEX) in humans [7] . Interestingly enough, some studies showed that a patient with mutations in expression of the CD25 gene developed an IPEX-like syndrome [8] . The regulatory functions of Tregs are mediated by cell-cell contact and also secretion of inhibitory cytokines such as IL-10, TGF-β, and IL-35. The association of high levels of IL-10 and IL-35 with autoimmune diseases suggests that these cytokines play a special role in their pathogenesis. Therefore, these cytokines act as a crucial modulator in immune regulation in the intestine and the acute inflammatory process of IBD [9, 10] . Given the unknown aetiology of the CD and the role of the Tregs in the regulation of immune responses, we have decided to assess Treg cells contribution to the complex pathogenesis of CD. In addition, we evaluated IL-10 and IL-35 concentrations in the co-culture supernatant.
MATERIALS AND METHODS

Human subjects
Twenty-three patients (12 men and 11 women) aged 37.04 ± 10.44 years (range 19 to 63 years) with CD were studied. The healthy control group (HC) consisted of 25 (13 males and 12 females) with mean age of 35.92 ± 9.72 years (range 20 to 56). All patients had not received any treatment. The diagnosis of this disease was performed according to established criteria including clinical history, physical and laboratory findings, and endoscopic and histo-pathologic features. Crohn's disease activity was actually assessed based on Harvey Bradshaw Index (HBI) [11] . Thus, the mean was 11.6 ± 2.25 (range: 9-16).
None of them had any autoimmune or underlying disorders. This study was approved by the Ethics Committee of Mazandaran University of Medical Sciences, and the written informed consent was obtained from all subjects before the study.
Peripheral blood mononuclear cells (PBMCs) sample collection
Peripheral whole blood (30 mL) was collected into an EDTA anti-coagulated tube. PBMCs were isolated from fresh whole blood samples using density gradient centrifugation (Biowest, Nuaille, France) based on the manufacturer's instructions. The cells in middle phase were collected and suspended (5×10 6 cells/mL) in RPMI 1640 medium supplemented with 100 mg/mL streptomycin, 100 U/mL penicillin, 10% heat-inactivated fetal calf serum (FCS) and 2mM L-glutamine (Gibco/BRL).
Flow cytometric analysis of Tregs
All antibodies and isotype controls were purchased from BD Biosciences (BD Biosciences, San Diego, CA, USA 
Isolation of T cell subsets
The rest of PBMCs were washed and resuspended in cold MACS buffer (PBS containing 0.5% BSA with 2 mM EDTA (Biowest, France)). Tregs were isolated from PBMCs in an aseptic condition by using the CD4 + CD25 + CD127
dim/-Regulatory T Cell Isolation Kit II (Miltenyi Biotec, Bergisch Gladbach, Germany) according to the manufacturer's instructions. Briefly, the cells were incubated with a cocktail of biotin-conjugated mAbs against CD8, CD19, CD123, and CD127 and then with microbeads coated to anti-biotin mAbs; CD127 low/-CD4 + enriched cells were isolated with negative selection after separation in a magnetic field. Next, the cells were incubated with anti-CD25-coated microbeads and subsequently CD4 +
CD25
+ CD127 low/-Treg cells purified by positive selection. To increase the purity, we repeated the second stage by using a new column. The isolation of CD4 + CD25 -responder (Tres) cells was performed with the CD4 + CD25 + Regulatory T Cell Isolation Kit (MiltenyiBiotec). Briefly, the cells were incubated with a cocktail of biotin-conjugated mAbs against CD8, CD14, CD16, CD19, CD36, CD56, CD123, TCRγ/δ, and CD235a (glycophorin A) and then with anti-biotin microbeads; CD4 + enriched cells were separated by negative selection. Afterwards, the cells were incubated with CD25 microbeads and subsequently CD4 + CD25 -Tres cells isolated as the negatively selected cell fraction after separation in a magnetic field. To increase the purity, the isolated cells underwent a second round of CD25 depletion. The purity of the separated CD4 + CD25 + CD127
low/-and CD4 + CD25 -cells was more than 94% and 90%, respectively.
In vitro suppression assay
To assess the suppressive capacity of regulatory T cells, freshly purified CD4 + CD25 + CD127
low/-Treg and CD4 + CD25 -Tres cells were labelled with CFSE dye (carboxyfluorescein diacetate succinimidyl ester) by using the Celltrace CFSE Cell Proliferation Kit (Invitrogen, Life Technologies), which is described in the following: Treg and Tres cells were re-suspended in PBS containing 0.1% BSA and labelled with 3µM of CFSE (final concentration, experimentally modified) and incubated at 37°C for 10 min. The reaction was stopped by adding 5 volumes of ice-cold culture media RPMI 1640 (Biowest) to the cells. The cells were incubated 5 min on ice, washed twice, and re-suspended in a fresh medium. Suppression assay was performed in 96-well roundbottom plates (SPL Life Sciences, Gyeonggi-do, South Korea). CFSE-labelled Treg and Tres cells were co-cultured at various ratios in RPMI media (final volume: 250 µL) supplemented with 10% heat-inactivated FBS, 100 U/mL penicillin, 100 µg/mL streptomycin, and 2 mM L-glutamine (Gibco, Life Technologies, CA). We used a ratio 
Statistical analysis
The data were analyzed by fifth version of GraphPad Prism software for Windows (GraphPad software, La Jolla, CA). Findings were expressed as mean ± SD. Comparisons between two groups were done using unpaired t-test (unpaired, twotailed) for normally distributed variables and the non-parametric Mann-Whitney test for non-normally distributed variables. The p values were considered significant when < 0.05.
RESULTS
Clinical characteristics of participants
Clinical and demographic data of CD patients and Subjects are presented in Table 1 . White blood cells count (×10 3 /µl) in CD patients (8.64 ± 1.05) was a significantly higher than in healthy controls (7.53 ± 1.36, P = 0.0048). There was significant difference in absolute counts of lymphocytes between the two groups, although the percentage of lymphocytes was lower in CD patients (28.43 ± 4.26) compared to HC (31.04 ± 4.33, P = 0.0415).
CD4
+ T cells are presented in Figure 1 . Figure 1 ). 
Treg cells and Tres cells co-culture
This study evaluated Treg-Tres co-culture experiment by using CD4 + CD25 high CD127 low cells as Tregs and CD4 + CD25 -cells as Tres cells with the CFSE dilution assay for all subjects. After CFSE-labelled cells' proliferation, the CFSE is equally distributed to division cells.When we calculated the percentage of Treg suppression, there was no significant difference suppressive capacity of Treg cells in patients compared with controls ( Figure 2, Figure 3 and Table 3 ). In CD patients there was a significant difference in secretion of IL-10 in response to anti-CD2/CD3/ CD28 in comparison with HC (P = 0.0074). The concentration of IL-10 in CD patients (78.52 ± 25.18 pg/mL) was lower than that in healthy controls (104.52 ± 37.31 pg/mL). There was no statistically significant difference in the concentration of IL-35 between the two groups (5.75 ± 2.53 ng/mL vs. 6.81 ± 3.34 ng/mL, p = 0.3027) (Figure 4 ). After Treg cells' isolation, they were cultured with anti-CD2/CD3/CD28 Macsibeads for 72 hours. Data is presented as mean ± SD.
DISCUSSION
Although recent studies in the pathophysiological mechanisms of CD have opened up promising avenues for CD treatment there are still a lot of unsolved issues. Regulatory T cells have a key role for preventing unwanted immunological reactions and are important for continued immune tolerance. FoxP3 is a cytoplasm protein molecule that is currently used for detection of Treg cells. FoxP3 is detected in the nucleus or the cytoplasm being necessary for regulating the anergic state of Tregs. However, there is no single surface-specific marker for isolation of Treg cells. CD4 CD25 in combination with low CD127 are important surface markers for isolation of high FoxP3 + Treg cells for co-culture experimental research.
In current study, CD patients have shown a lower frequency of CD4 + CD25 + CD127 low FoxP3 + Tregs in comparison with HC. Similar with our data, some studies showed lower frequency of Treg cells in active CD patients [12, 13] . Maul et al. described that in peripheral blood of patients with active IBD, CD4 + CD25 high FOXP3 + T cells were decreased. [14] . Unlike our research, Guidi et al.
reported no differences in Treg cell frequency between IBD patients and healthy controls [15] . On the other hand, our data showed that the inhibitory effect of Treg cells in CD patients did not decrease during active stage of disease. In agreement with us, other studies showed a higher or even normal inhibitory effect of Treg cells [16] [17] [18] . These suppressor cells which migrate to local inflammation lead to this phenomenon. Therefore frequency of functional Treg was decreased in peripheral blood. Saruta et al., showed that there was an expansion of Treg cells in mucosal lymphoid tissues and inflammatory sites of CD patients [19] . Low activity and low frequency of Treg cells could be an important factor for inflammation responses in CD patients [20] . In this study, high disease activity in CD patients resulted in decreased Treg cell frequency and inhibitory capacity. Differences from previous reported data may come from differences in patients recruited, disease duration and methods used for Treg cells evaluation.
IL-10 and IL-35 promote the expansion or survival of regulatory function in Treg cells [21, 22] . IL-10 plays crucial roles in regulation of important biological processes, including cell-cycle 165 arrest, senescence, and induction of apoptosis. Therefore, low suppressive functions of Treg cells in co-culture with T-res related to low IL-10 and some others in CD patients. In the present study, there was a low concentration of IL-10 in culture media supernatant compared with HC. Franke et al. reported that IL-10 is an immunoregulatory cytokine that has been considered to influence IBD pathophysiology [23] . Defective IL-10 function is crucial for IBD pathogenesis [23] . In fact, IL-10 produced by macrophages is important for T-regulatory cell-mediated prevention of IBD [24, 25] .
Most We suggest that an alteration in Tregs and T effectors balance may be necessary in defective suppression observed in these patients thus providing critical role in CD pathogenesis.
